Lactobacillus gasseri endocarditis on the aortic valve bioprosthesis – a case report;Lactobacillus gasseri jako czynnik etiologiczny zapalenia wsierdzia na bioprotezie zastawki aortalnej

Polski Merkuriusz Lekarski

Volumn 43, Issue 257, 2017, Pages 220-223

  Elikowski, W ^a   Malek Elikowska M ^a   Lisiecka, M ^b   Bodora, A ^a   Wisniewska K ^a   Oko Sarnowska, Z ^a  

^a Jozef Strus Hospital   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

aortic valve prosthesis; infective endocarditis; Lactobacillus gasseri; probiotics

Indexed keywords

ANTIINFECTIVE AGENT;

AORTIC VALVE; BACTERIAL ENDOCARDITIS; CASE REPORT; DIAGNOSTIC IMAGING; DRUG EFFECTS; FEMALE; HEART VALVE PROSTHESIS; HUMAN; LACTOBACILLUS GASSERI; MICROBIOLOGY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VERY ELDERLY;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AORTIC VALVE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE PROSTHESIS; HUMANS; LACTOBACILLUS GASSERI;

EID: 85044695475     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aaron JG, Sobieszczyk ME, Weiner SD, et al.: Lactobacillus rhamnosus Endocarditis After Upper Endoscopy. Open Forum Infect Dis, 2017; 4: ofx085.
2. Asahara T, Takahashi M, Nomoto K, et al.: Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol, 2003; 10: 169-173.
3. Bayer AS, Chow AW, Betts D, et al.: Lactobacillemia – report of nine cases. Important clinical and therapeutic considerations. Am J Med, 1978; 64: 808-813.
4. Botros M, Mukundan D.: Lactobacillus endocarditis with prosthetic material: a case report on non-surgical management with corresponding literature review. Infect Dis Rep, 2014; 6: 5497.
5. Cannon JP, Lee TA, Bolanos JT, et al.: Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005; 24: 31-40.
6. Chaini E, Chainis ND, Ioannidis A, et al.: Pneumonia and Pleural Empyema due to a Mixed Lactobacillus spp. Infection as a Possible Early Esophageal Carcinoma Signature. Front Med (Lausanne), 2016; 3:42. eCollection 2016.
7. Crovesy L, Ostrowski M, Ferreira DMTP, et al.: Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials. Int J Obes (Lond), 2017;161, doi: 10.1038/ijo. [Epub ahead of print]
8. Davies AJ, James PA, Hawkey PM.: Lactobacillus endocarditis. J Infect, 1986;12: 169-174.
9. Dickgiesser U, Weiss N, Fritsche D.: Lactobacillus gasseri as the cause of septic urinary infection. Infection, 1984; 12: 14-16.
10. Fradiani PA, Petrucca A, Ascenzioni F, et al.: Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient. J Med Microbiol 2010 59: 607-609 com
11. , 11. Franko B, Vaillant M, Recule C, et al.: Lactobacillus paracasei endocarditis in a consumer of probiotics. Med Mal Infect, 2013; 43: 171-173. press.
12. Gallemore GH, Mohon RT, Ferguson DA.: Lactobacillus fermentum endocarditis involving a native mitral valve. J Tenn Med Assoc, 1995; 88: 306-368. @me
13. Griffiths JK, Daly JS, Dodge RA.: Two cases of endocarditis due to Lactobacillus species: antimicrobial susceptibility, review, and discussion of therapy. Clin Infect Dis, 1992; 15: 250-255. edpres
14. Harty DW, Oakey HJ, Patrikakis M, et al.: Pathogenic potential of lacto-bacilli. Int J Food Microbiol, 1994; 24:179-189.
15. Husni RN, Gordon SM, Washington JA, et al.: Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis, 1997; 25: 1048-1055.
16. Isenberg D.: Lactobacillus infective endocarditis. Proc R Soc Med, 1977; 70: 278-281.
17. Kato K, Funabashi N, Takaoka H, et al.: Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis. Int J Cardiol, 2016; 224:157-161.
18. Kestler M, Muńoz P, Marín M, et al.; Spanish Collaboration on Endocarditis (GAMES).: Endocarditis caused by anaerobic bacteria. Anaerobe, 2017; 47: 33-38.
19. Kobayashi R, Kobayashi T, Sakai F, et al.: Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. Sci Rep, 2017; 7: 545.
20. Lara-Villoslada F, Sierra S, Martín R, et al.: Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714. J Appl Microbiol, 2007; 103: 175-184.
21. Mackay AD, Taylor MB, Kibbler CC, et al.: Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect, 1999; 5: 290-292.
22. Makaryus AN, Yang R, Hahn RT, et al.: A rare case of Lactobacillus acidophilus presenting as mitral valve bacterial endocarditis. Echocardiography, 2005; 22: 421-425.
23. Meier B, Fischer E, Lüthy R, et al.: Lactobacillus casei endocarditis after aortic valve prosthesis. Schweiz Med Wochenschr, 1981; 111: 601-603.
24. Monterisi A, Dain AA, Suárez de Basnec MC, et al.: Native-valve endocarditis produced by Lactobacillus casei sub. rhamnosus refractory to antimicrobial therapy. Medicina (B Aires), 1996; 56: 284-286.
25. Noreńa I, Cabrera-Marante O, Fernández-Ruiz M.: Endocarditis due to Lactobacillus rhamnosus in a patient with bicuspid aortic valve: Potential role for the consumption of probiotics? Med Clin (Barc), 2017;149: 181-182.
26. Penot JP, Lagrange P, Darodes N, et al.: Lactobacillus acidophilus endocarditis. Presse Med, 1998; 27: 1009-1012.
27. Presterl E, Kneifel W, Mayer HK, et al.: Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis, 2001; 33: 710-714.
28. Recio R, Chaves F, Reyes CA, et al.: Infective endocarditis due to Lactobacillus rhamnosus: Risks of probiotic consumption in a patient with structural heart disease. Enferm Infecc Microbiol Clin, 2017. pii: S0213-005X(17)30098-8. doi: 10.1016/j.eimc.2017.02.004. [Epub ahead of print]
29. Rogasi PG, Vigano S, Pecile P, et al.: Lactobacillus casei pneumonia and sepsis in a patient with AIDS. Case report and review of the literature. Ann Ital Med Int, 1998;13: 180-182.
30. Salminen MK, Rautelin H, Tynkkynen S, et al.: Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis, 2006; 42: e 35-44.
31. Salminen MK, Tynkkynen S, Rautelin H, et al.: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis, 2002; 35: 1155-1160.
32. Salvana EM, Frank M.: Lactobacillus endocarditis: case report and review of cases reported since 1992. J Infect, 2006; 53: e5-e10.
33. See JRH, MD, Czachor JS, Brown GR.: Lactobacillus Endocarditis Case Report and Literature Review. Infect Dis Clin Pract, 2006; 14: 134-136.
34. Selle K, Klaenhammer TR.: Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health. FEMS Microbiol Rev, 2013; 37: 915-935.
35. Sussman JI, Baron EJ, Goldberg SM, et al.: Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature. Rev Infect Dis, 1986; 8: 771-776.
36. Tleyjeh IM, Routh J, Qutub MO, et al.: Lactobacillus gasseri causing Fournier’s gangrene. Scand J Infect Dis, 2004; 36: 501-503.
37. Tommasi C, Equitani F, Masala M, et al.: Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report. J Med Case Rep, 2008; 2: 315.
38. Urkijo JC, Montejo M, Mendoza MF, et al.: Endocarditis caused by Lactobacillus. Enferm Infecc Microbiol Clin. 1992; 10: 32-33.
39. Wallet F, Dessein R, Armand S, et al.: Molecular diagnosis of endocarditis due to Lactobacillus casei subsp. rhamnosus. Clin Infect Dis, 2002; 35: e117-119.
40. Vankerckhoven V, Moreillon P, Piu S, et al.: Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. J Med Microbiol, 2007; 56: 1017-1024.